Welcome to the Illinois Cancer Research Fund (ICRF)
The ACS Illinois Area Board created the Illinois Cancer Research Fund (ICRF) with the goal of having all approved research projects led by investigators at Illinois-based institutions funded.
Welcome to the Illinois Cancer Research Fund (ICRF)
The ACS Illinois Area Board created the Illinois Cancer Research Fund (ICRF) with the goal of having all approved research projects led by investigators at Illinois-based institutions funded.
Welcome to the Illinois Cancer Research Fund (ICRF)
The ACS Illinois Area Board created the Illinois Cancer Research Fund (ICRF) with the goal of having all approved research projects led by investigators at Illinois-based institutions funded.
Ray Young
Executive Vice President and Chief Financial Officer
Archer Daniels Midland Company
Ray G. Young is executive vice president and chief financial officer of Archer Daniels Midland Company, and a member of the company’s Executive Council. In his role, he oversees the company’s accounting, controlling, treasury, tax, financial planning, and investor relations activities as well as the ADM Investor Services organization. Young is also responsible for strategic oversight of ADM’s business in Asia.
Young joined ADM in 2010 following a 24-year tenure with General Motors Co., during which he held executive leadership positions in finance, general management, planning and operations on four continents. Young served in Shanghai as vice president of GM International Operations, and in 2008 and 2009, he was CFO of General Motors. Between 2004 and 2007, he was the president and managing director of GM do Brasil and Mercosur Operations, based in São Paulo.
Young graduated in 1984 from The Ivey School of Business, University of Western Ontario, in London, Canada, with a bachelor’s degree in business administration. He holds an MBA from the University of Chicago.
Young serves on the boards of directors of International Paper Company, Wilmar International and the U.S.-China Business Council. He is also a member of the board of directors of the American Cancer Society Illinois Division and the CFO Advisory Board of the University of Chicago Booth School of Business.
Ken Hallman
Principal
Inoca Consulting
Ken Hallman is currently a Principal at Inoca Consulting providing strategy and product management advisory services.
Ken has over 30 years of experience in general management, strategic planning and product management & development. He previously held senior leadership positions at various global companies including Schneider Electric, Motorola/Google, Verizon, Sears Holdings and Verisign. He has led several multi-billion-dollar product families, including the Kenmore brand and the Motorola Droid product family.
John Greene
Executive Vice President & Chief Financial Officer
Discover
John T. Greene joined Discover in September 2019 as executive vice president, chief financial officer. Prior to joining Discover, John served as executive vice president, chief financial officer and treasurer at Bioverativ, a global biopharmaceutical company. From 2014 to 2016, he was chief financial officer for Willis Group Holdings, which was preceded by more than eight years at HSBC Holdings where he held CFO positions for several divisions, including retail bank and wealth management; insurance and consumer and mortgage lending. He also held various CFO roles in his 12-year tenure with General Electric from 1993 to 2005. John holds a bachelor’s degree in accounting from the State University of New York and a master’s degree in Business Administration from the Kellogg School of Management at Northwestern University..
Emily fitzgerald
Partner
Swanson, Martin & Bell, LLP
Emily Fitzgerald is a litigation partner at Swanson, Martin & Bell, LLP. Emily serves as national counsel for businesses and corporate clients in state and federal jurisdictions managing commercial litigation, business disputes, business contracts, products liability, and class actions. Emily advises clients in numerous industries, including food and beverage, financial services, insurance, construction, transportation, technology, and healthcare.
Emily graduated with a B.A. from the University of Notre Dame. She received her J.D. from the University of Illinois College of Law.
Funding Partners
Welcome to the Illinois Cancer Research Fund (ICRF)
The ACS Illinois Area Board created the Illinois Cancer Research Fund (ICRF) with the goal of having all approved research projects led by investigators at Illinois-based institutions funded.
impact Through Research We Conduct
Cancer Prevention Studies for a Cancer-free tomorrow
The American Cancer Society conducts long-term studies that help us better understand the causes of cancer and how to prevent the disease. These studies have shown how lifestyle, environmental, genetic and other factors relate to cancer risk and how they ultimately played a role in the 29% drop in cancer death rates between 1991 and 2017.
How do we conduct cancer prevention studies?
What are some of our studies findings and their impact?
addressing Health Equity through research
Funding Scientists who conduct research
The American Cancer Society funds scientists who conduct research about cancer at medical schools, universities, research institutes, and hospitals throughout the United States. We use a rigorous and independent peer review process to select the most innovative research projects proposals to fund. To-date, the Society has invested more than $300 million, funding 550 grants. Initial investigations focused on gathering data to document that health inequities exist; then studies moved to identifying the multi-factorial causes; since 2013, the focus has been on solution-based strategies.
current funding totals as of August 1, 2021
Establishing Cancer Health Equity Research Centers at Minority Serving Institutions (MSIs)
|
The American Cancer Society awarded over $16 million in grants to establish Cancer Health Equity Research Centers (CHERC) at Minority Serving Institutions (MSIs) in 2022.
The inaugural cohort of institutions includes the Arizona Board of Regents – University of Arizona; the University of Illinois at Chicago; Morehouse School of Medicine and Howard University. Each institution received a four-year grant of $4.08 million.
The institutions selected in the initial cohort will implement solution-based research addressing cancer health disparities that will contribute to achieving health equity and reducing cancer mortality.
|
|
Paving the way to a future of more diverse cancer researchers
|
University of Kentucky Diversity in Cancer Research Internship Recipients from 2021. |
Diverse perspectives in research are an essential component of driving innovative problem-solving that accelerates new approaches to the prevention and treatment of cancer. To improve diversity in the field of cancer research, the American Cancer Society launched a new grant program awarding funding to universities to implement its Diversity in Cancer Research (DICR) Internship program.
Made possible by a $5 million grant from the Elizabeth and Phil Gross Family, the American Cancer Society DICR pilot launched in 2021 with 32 interns at Emory University, Georgetown University, the University of Chicago, the University of Colorado, the University of Kentucky, the University of Maryland, the University of New Mexico, and Washington University. The goal of the DICR Internship program is to enroll 100 interns per year over ten years.
In 2022, 12 universities are receiving DICR Internship grants, including: Yale University School of Medicine; Emory University; Case Western Reserve University; the University of Chicago; Indiana University; University of Kentucky Research Foundation; University of Colorado Denver Anschutz Medical Campus; University of New Mexico Health Sciences Center; Georgetown University; Board of Regents of the University of Oklahoma Health Sciences Center; University of Maryland, Baltimore; and Washington University in St. Louis. |
Impact Through research we fund
Ten of the countless cancer advances supported by the American Cancer Society
 |
The success of the American Cancer Society grant program is exemplified by the fact that 50 American Cancer Society-funded researchers have received a Nobel Prize for their work. |
 |
Carolyn Bertozzi, PhD, was one of three scientists to be awarded the 2022 Nobel Prize in Chemistry for the development of click chemistry and bio-orthogonal chemistry. She is the 50th American Cancer Society-funded researcher and the first woman researcher funded by ACS to win the prestigious honor. Learn more about her work. |
Research Informs Advocacy And Policy Actions
The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society. Its role is to support evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. American Cancer Society (ACS) researchers collaborate with ACS CAN staff to explore how and why certain groups of people in the US are not benefitting from health care services such as cancer prevention, early detection, and treatment.
ACS CAN is attacking disparities by changing or adding new evidence-based public health policies at the local, state, and federal levels. The goal of ACS CAN is to reduce these disparities and improve health outcomes for all US population groups regardless of race, ethnicity, gender, age, sexual orientation, socioeconomic status, or zip code.
Reducing barriers to patient enrollment in cancer clinical trials
Welcome to the Illinois Cancer Research Fund (ICRF)
The ACS Illinois Area Board created the Illinois Cancer Research Fund (ICRF) with the goal of having all approved research projects led by investigators at Illinois-based institutions funded.